Jiangsu Zhongzhi Pharmaceutical

Jiangsu Zhongzhi Pharmaceutical is a China-based pharmaceutical company focused on the research, development, and manufacturing of finished dosage forms and active pharmaceutical ingredients (APIs). The company specializes in several therapeutic areas, including central nervous system (CNS) disorders, cardiovascular diseases, and metabolic conditions. Its product portfolio includes generic versions of widely used medications such as Aripiprazole for schizophrenia and various treatments for hypertension. Jiangsu Zhongzhi operates modern manufacturing facilities that comply with Chinese GMP standards, supporting both domestic supply and international export of high-quality chemical drugs.